chevron_leftBack
As of 16 June 2026, Tonghua Dongbao Pharmaceutical Co., Ltd. has a market cap of $2.74B USD, ranking #5778 globally and #1284 in China.
It ranks #453 in the Healthcare sector, and #179 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$2.74BUSD
18.58B CNY
Enterprise Value
$2.6BUSD
17.61B CNY
Revenue (TTM)
$449.45MUSD
3.04B CNY
EBITDA (TTM)
$141.01MUSD
954.28M CNY
Net Income (TTM)
$182.63MUSD
1.24B CNY
EBITDA Margin
31%
Profit Margin
41%
PE Ratio
15.8
Forward PE
27.2
PS Ratio
6.1
PB Ratio
2.6
EV/EBITDA
18.4
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Chun Sheng Leng
open_in_new
Employees
3,410
Founded
1985
Website
thdb.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -3.5% | -3% | 4.2% | 5.1% | 2% | 23% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
600867
通化东宝药业股份有限公司 Class A
ISIN: CNE000000H87
Shares Out.:
Shares Outstanding:
1.937B1
Shares Float:
1.137B2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
9.23 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Tonghua Dongbao Pharmaceutical Co., Ltd.
Tonghua Dongbao Pharmaceutical Co., Ltd. researches, develops, produces, and markets pharmaceuticals in China. It offers human insulin injections; insulin glargine injections; insulin aspart injections; liraglutide injections; and proprietary Chinese medicine. The company also provides insulin pen and pen needles; and chronic disease management platform, a diabetes management platform for drug treatment, blood glucose monitoring, and patient education. In addition, it offers chemical drugs, such as repaglinide, sitagliptin phosphate, and metformin hydrochloride tablets. Tonghua Dongbao Pharmaceutical Co., Ltd. was founded in 1985 and is headquartered in Tonghua, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SSE: 600276
|
$53.89B
2K%
364.89B CNY
|
44.9
|
|
SSE: 603259
|
$49.67B
2K%
336.36B CNY
|
17.2
|
|
SHEK: 3692
|
$28.52B
940%
223.48B HKD
|
35.7
|
|
SHEK: 1801
|
$18.8B
585%
147.32B HKD
|
162.3
|
|
SSE: 688506
|
$16.52B
502%
111.89B CNY
|
-
|
|
SHEK: 9926
|
$16.01B
484%
125.46B HKD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
28K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
20K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
13K%
|
97.4
|
|
SIX: RO
|
$322.73B
12K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$289.3B
10K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$275.68B
10K%
218.9B CHF
|
20.5
|
chevron_leftBack